The recombinant immunodominant regions 179-344 and 550-670 from SARS-COV2 spike protein can efficiently react with patients' sera
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.107604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Sama Lotfian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19, Antibodies, Viral. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Zanjan University of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
- Department of Medical Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
- Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran; Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran. Electronic address:…
Förderung
- Zanjan University of Medical Sciences
Zitieren
APA
Lotfian, S., Soleimani, A., Taromchi, A. H., Sabzehei, F., Dinmohammadi, H., & Nedaei, K. (2025). The recombinant immunodominant regions 179-344 and 550-670 from SARS-COV2 spike protein can efficiently react with patients' sera. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107604
Vancouver
Lotfian S, Soleimani A, Taromchi AH, Sabzehei F, Dinmohammadi H, Nedaei K. The recombinant immunodominant regions 179-344 and 550-670 from SARS-COV2 spike protein can efficiently react with patients' sera. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107604
BibTeX
@article{Lotfian2025,
author = {Lotfian, Sama and Soleimani, Akbar and Taromchi, Amir Hossein and Sabzehei, Faezeh and Dinmohammadi, Hossein and Nedaei, Keivan},
title = {The recombinant immunodominant regions 179-344 and 550-670 from SARS-COV2 spike protein can efficiently react with patients' sera},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.107604}
}
EUVIMED